193014-01-6 Usage
General Description
Benzoic acid, 3-amino-2-nitro-, ethyl ester (9CI) is a chemical compound that belongs to the class of esters. It is formed from the reaction of benzoic acid, which is a carboxylic acid, with ethyl alcohol. The compound contains an amino group and a nitro group, which makes it useful in various chemical reactions and as a building block for the synthesis of other compounds. It is commonly used in the production of pharmaceuticals, dyes, and fragrances. Benzoic acid, 3-amino-2-nitro-, ethyl ester (9CI) has potential applications in the field of medicine and organic chemistry due to its unique chemical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 193014-01-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,3,0,1 and 4 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 193014-01:
(8*1)+(7*9)+(6*3)+(5*0)+(4*1)+(3*4)+(2*0)+(1*1)=106
106 % 10 = 6
So 193014-01-6 is a valid CAS Registry Number.
193014-01-6Relevant articles and documents
Benzimidazole compounds
-
Page column 65, (2010/02/05)
A benzimidazole compound represented by the formula (I): wherein R3is a carboxyl group, a esterified carboxyl group, an amidated carboxyl group, an amino group, an amido group, or a sulfonyl group, or their pharmaceutically acceptable salts. Because of their blood sugar-depressing effect or PDE5 inhibitory effect, these compounds or salts thereof are useful as medicines for treating impaired glucose tolerance, diabetes, diabetic complications, syndrome of insulin resistance, hyperlipidemia, atherosclerosis, cardiovascular disorders, hyperglycemia, or hypertension; or stenocardia, hypertension, pulmonary hypertension, congestive heart failure, glomerulopathy, tubulointerstitial disorders, renal failure, atherosclerosis, angiostenosis, distal angiopathy, cerebral apoplexy, chronic reversible obstructions, allergic rhinitis, urticaria, glaucoma, diseases characterized by enteromotility disorders, impotence, diabetic complications, nephritis, cancerous cachexia, or restenosis after PTCA.
